Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-03-23 Sale |
2023-03-27 4:05 pm |
Cue Biopharma Inc. | CUE | Kiener Peter A Director |
9,325 | $3.28 | $30,586 | 96,419 (Direct) |
View |
| 2022-05-27 Purchase |
2022-05-31 4:06 pm |
Cue Biopharma Inc. | CUE | Morich Frank Director |
28,000 | $3.75 | $105,000 | 28,000 (Direct) |
View |
| 2022-05-23 Purchase |
2022-05-25 09:09 am |
Cue Biopharma Inc. | CUE | Fletcher Aaron G.L. Director |
205,000 | $3.4717 | $711,700 | 1,113,867 (Indirect Direct) |
View |
| 2022-03-31 Purchase |
2022-04-04 5:28 pm |
Cue Biopharma Inc. | CUE | Fletcher Aaron G.L. Director |
735,000 | $4.76 | $3,498,600 | 908,867 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-07-21 Option Award |
2023-07-25 12:27 pm |
N/A 2033-07-20 |
Cue Biopharma Inc. | CUE | Sandercock Colin SVP, GENERAL COUNSEL |
75,000 | $0 | 75,000 (Direct) |
View |
| 2023-07-21 Option Award |
2023-07-25 12:25 pm |
N/A 2033-07-20 |
Cue Biopharma Inc. | CUE | Suri Anish PRESIDENT AND CSO |
124,125 | $0 | 124,125 (Direct) |
View |
| 2023-04-19 Option Award |
2023-04-21 4:15 pm |
N/A 2033-04-18 |
Cue Biopharma Inc. | CUE | Garzone Pamela Director |
40,000 | $0 | 40,000 (Direct) |
View |
Ownership |
2023-04-13 4:43 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | Verheyen Patrick Director |
0 | $0 | 8,174 (Direct) |
View |
| 2023-04-11 Option Award |
2023-04-13 4:42 pm |
N/A 2033-04-10 |
Cue Biopharma Inc. | CUE | Verheyen Patrick Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-03-23 Exercise |
2023-03-27 4:05 pm |
N/A 2023-03-23 |
Cue Biopharma Inc. | CUE | Kiener Peter A Director |
9,682 | $0 | 96,419 (Direct) |
View |
| 2023-03-23 Exercise |
2023-03-27 4:05 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | Kiener Peter A Director |
9,682 | $2.86 | 96,419 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-21 5:03 pm |
N/A 2033-02-15 |
Cue Biopharma Inc. | CUE | NASSHORN PATRICIA Chief Business Officer |
97,900 | $0 | 97,900 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-21 5:01 pm |
N/A 2033-02-15 |
Cue Biopharma Inc. | CUE | Suri Anish PRESIDENT AND CSO |
125,500 | $0 | 125,500 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-21 5:00 pm |
N/A 2033-02-15 |
Cue Biopharma Inc. | CUE | Sandercock Colin SVP, GENERAL COUNSEL |
100,000 | $0 | 100,000 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-21 4:59 pm |
N/A 2033-02-15 |
Cue Biopharma Inc. | CUE | PASSERI DANIEL R CHIEF EXECUTIVE OFFICER |
324,000 | $0 | 324,000 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-21 4:58 pm |
N/A 2033-02-15 |
Cue Biopharma Inc. | CUE | Millar Kerri-Ann CHIEF FINANCIAL OFFICER |
124,000 | $0 | 124,000 (Direct) |
View |
| 2023-01-17 Option Award |
2023-01-19 4:02 pm |
N/A 2033-01-16 |
Cue Biopharma Inc. | CUE | Levisetti Matteo Chief Medical Officer |
110,000 | $0 | 110,000 (Direct) |
View |
Ownership |
2023-01-19 4:01 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | Levisetti Matteo Chief Medical Officer |
0 | $0 | 137,230 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:11 pm |
N/A 2033-01-02 |
Cue Biopharma Inc. | CUE | Morich Frank Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:10 pm |
N/A 2033-01-02 |
Cue Biopharma Inc. | CUE | Kiener Peter A Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:09 pm |
N/A 2033-01-02 |
Cue Biopharma Inc. | CUE | HOWSON TAMAR D Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:08 pm |
N/A 2033-01-02 |
Cue Biopharma Inc. | CUE | Fletcher Aaron G.L. Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:08 pm |
N/A 2033-01-02 |
Cue Biopharma Inc. | CUE | DRISCOLL FREDERICK W Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2022-08-21 Exercise |
2022-08-23 4:03 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | Millar Kerri-Ann CHIEF FINANCIAL OFFICER |
6,667 | $0 | 14,311 (Direct) |
View |
| 2022-08-22 Tax Withholding |
2022-08-23 4:03 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | Millar Kerri-Ann CHIEF FINANCIAL OFFICER |
2,828 | $3.05 | 14,311 (Direct) |
View |
| 2022-06-14 Tax Withholding |
2022-06-16 4:01 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | Gray Cameron Director |
51,562 | $3.2 | 687,049 (Direct) |
View |
| 2022-06-14 Exercise |
2022-06-16 4:01 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | Gray Cameron Director |
61,111 | $2.7 | 687,049 (Direct) |
View |
| 2022-06-14 Exercise |
2022-06-16 4:01 pm |
2015-06-15 2022-06-15 |
Cue Biopharma Inc. | CUE | Gray Cameron Director |
61,111 | $0 | 687,049 (Direct) |
View |
| 2022-03-31 Exercise |
2022-04-04 5:31 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | Suri Anish PRESIDENT AND CSO |
16,668 | $0 | 103,638 (Direct) |
View |
| 2022-03-31 Tax Withholding |
2022-04-04 5:31 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | Suri Anish PRESIDENT AND CSO |
7,068 | $4.88 | 103,638 (Direct) |
View |
| 2022-03-31 Gift |
2022-04-04 5:29 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | PASSERI DANIEL R CHIEF EXECUTIVE OFFICER |
10,000 | $0 | 131,578 (Direct) |
View |
| 2022-03-31 Exercise |
2022-04-04 5:29 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | PASSERI DANIEL R CHIEF EXECUTIVE OFFICER |
75,000 | $0 | 131,578 (Direct) |
View |
| 2022-03-31 Tax Withholding |
2022-04-04 5:29 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | PASSERI DANIEL R CHIEF EXECUTIVE OFFICER |
32,122 | $4.88 | 131,578 (Direct) |
View |
| 2022-03-25 Option Award |
2022-03-29 5:22 pm |
N/A 2032-03-24 |
Cue Biopharma Inc. | CUE | NASSHORN PATRICIA Chief Business Officer |
10,000 | $0 | 10,000 (Direct) |
View |
| 2022-02-09 Option Award |
2022-03-29 4:15 pm |
N/A 2032-02-08 |
Cue Biopharma Inc. | CUE | Suri Anish PRESIDENT AND CSO |
103,333 | $0 | 103,333 (Direct) |
View |
| 2022-02-09 Option Award |
2022-03-29 4:13 pm |
N/A 2032-02-08 |
Cue Biopharma Inc. | CUE | Sandercock Colin SVP, GENERAL COUNSEL |
76,667 | $0 | 76,667 (Direct) |
View |
| 2022-03-25 Option Award |
2022-03-29 4:12 pm |
N/A 2032-03-24 |
Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-03-25 Option Award |
2022-03-29 4:08 pm |
N/A 2032-03-24 |
Cue Biopharma Inc. | CUE | PASSERI DANIEL R CHIEF EXECUTIVE OFFICER |
100,000 | $0 | 100,000 (Direct) |
View |
| 2022-02-09 Option Award |
2022-03-29 4:05 pm |
N/A 2032-02-08 |
Cue Biopharma Inc. | CUE | Millar Kerri-Ann CHIEF FINANCIAL OFFICER |
95,000 | $0 | 95,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 9:14 pm |
N/A 2032-01-02 |
Cue Biopharma Inc. | CUE | Fletcher Aaron G.L. Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 8:27 pm |
N/A 2032-01-02 |
Cue Biopharma Inc. | CUE | Kiener Peter A Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 8:25 pm |
N/A 2032-01-02 |
Cue Biopharma Inc. | CUE | Morich Frank Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 8:24 pm |
N/A 2032-01-02 |
Cue Biopharma Inc. | CUE | HOWSON TAMAR D Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 8:22 pm |
N/A 2032-01-02 |
Cue Biopharma Inc. | CUE | DRISCOLL FREDERICK W Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 8:21 pm |
N/A 2032-01-02 |
Cue Biopharma Inc. | CUE | Gray Cameron Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2021-12-15 Option Award |
2022-01-04 5:00 pm |
N/A 2031-12-15 |
Cue Biopharma Inc. | CUE | NASSHORN PATRICIA Chief Business Officer |
100,000 | $0 | 100,000 (Direct) |
View |